(Q54727452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

editorial

0 references

title

EML4-ALK: honing in on a new target in non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

2

William Pao

1 reference

3 June 2018

Leora Horn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

William Pao

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

10 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

4232-4235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

EML4-ALK fusion lung cancer: a rare acquired event

5 February 2020

cites work

1 reference

12 December 2020

Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors

1 reference

12 December 2020

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

12 December 2020

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

12 December 2020

EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers

1 reference

12 December 2020

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

1 reference

12 December 2020

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

1 reference

12 December 2020

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

1 reference

12 December 2020

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

1 reference

12 December 2020

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

1 reference

12 December 2020

Activating mutations in ALK provide a therapeutic target in neuroblastoma

1 reference

12 December 2020

Oncogenic mutations of ALK kinase in neuroblastoma

1 reference

12 December 2020

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

12 December 2020

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

1 reference

12 December 2020

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

1 reference

12 December 2020

Somatic mutations affect key pathways in lung adenocarcinoma

1 reference

12 December 2020

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

12 December 2020

Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

1 reference

12 December 2020

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

12 December 2020

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

1 reference

12 December 2020

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

1 reference

12 December 2020

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

1 reference

12 December 2020

EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas

1 reference

12 December 2020

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

A mouse model for EML4-ALK-positive lung cancer

1 reference

12 December 2020

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

1 reference

12 December 2020

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2009.23.6661

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19667260%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference